• 1. Stabilization of organic field-effect transistors in hexamethylenetetrathiafulvalene derivatives substituted by bulky alkyl groups
  Masato Kanno,Yoshimasa Bando,Takashi Shirahata,Jun-ichi Inoue,Hiroshi Wada,Takehiko Mori J. Mater. Chem. 2009 19 6548

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Medium-chain fatty acids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates Medium-chain fatty acids

Introduction to 3-(tert-Butyl)hexanedioic acid (CAS No. 10347-88-3)

3-(tert-Butyl)hexanedioic acid, with the chemical formula C₁₀H??O?, is a significant compound in the field of organic chemistry and pharmaceutical research. Its molecular structure, featuring a hexanedioic acid backbone substituted with a tert-butyl group, imparts unique chemical properties that make it valuable in various applications, particularly in drug synthesis and material science. This introduction delves into the compound's characteristics, synthesis methods, and its emerging role in contemporary scientific research.

The CAS No. 10347-88-3 uniquely identifies this molecule in scientific literature and databases, ensuring precise referencing in academic and industrial contexts. The presence of the hexanedioic acid moiety, also known as adipic acid derivative, contributes to its reactivity and utility in forming ester linkages, which are crucial in peptide mimetics and polymer chemistry. The tert-butyl group, on the other hand, enhances the compound's stability and lipophilicity, making it an attractive candidate for drug delivery systems.

In recent years, 3-(tert-Butyl)hexanedioic acid has garnered attention for its potential applications in medicinal chemistry. Researchers have explored its use as an intermediate in the synthesis of non-peptide inhibitors targeting enzyme inhibition. For instance, derivatives of this compound have been investigated for their ability to modulate metabolic pathways by inhibiting key enzymes such as fatty acid synthase and acetyl-CoA carboxylase. These studies highlight the compound's role in developing treatments for metabolic disorders and obesity-related conditions.

The synthesis of 3-(tert-Butyl)hexanedioic acid typically involves multi-step organic reactions starting from commercially available precursors like hexanediol or butyl chloride. Advanced synthetic techniques, including catalytic hydrogenation and oxidation processes, are employed to achieve high yields and purity. The introduction of the tert-butyl group often requires careful control of reaction conditions to prevent side products, underscoring the importance of precise synthetic methodologies.

One of the most compelling aspects of 3-(tert-Butyl)hexanedioic acid is its versatility in material science applications. Its ability to form stable esters and polymers makes it a valuable component in producing biodegradable plastics and specialty coatings. These materials are increasingly important in sustainable chemistry, where reducing environmental impact is a primary goal. Additionally, the compound's compatibility with other functional groups allows for further modifications, enabling tailored properties for specific industrial needs.

Recent advancements in computational chemistry have also enhanced our understanding of 3-(tert-Butyl)hexanedioic acid's reactivity. Molecular modeling studies predict its interaction with biological targets with high accuracy, aiding in the design of novel therapeutic agents. These computational approaches complement experimental work by providing insights into binding affinities and metabolic stability, thereby accelerating drug discovery pipelines.

The pharmaceutical industry has been particularly interested in exploring 3-(tert-Butyl)hexanedioic acid as a building block for complex drug molecules. Its structural features allow for easy incorporation into larger scaffolds while maintaining bioactivity. For example, researchers have synthesized peptidomimetics that mimic natural bioactive peptides but exhibit improved pharmacokinetic profiles due to the incorporation of this compound. Such innovations underscore its significance as a pharmacophore in modern drug development.

In conclusion, 3-(tert-Butyl)hexanedioic acid (CAS No. 10347-88-3) is a multifaceted compound with broad applications across organic synthesis, pharmaceuticals, and material science. Its unique structural attributes enable diverse functionalities, making it indispensable in both academic research and industrial development. As scientific understanding progresses, new possibilities for utilizing this compound will continue to emerge, reinforcing its importance in advancing chemical innovation.

• 87272-22-8(OCTADECANEDIOIC ACID, 3,3,16,16-TETRAMETHYL-)
• 67727-45-1(HEPTANOIC ACID, 3-METHYL-3-PROPYL-, (-)-)
• 403858-38-8(HEXADECANEDIOIC ACID, 8,9-DIETHYL-8,9-DIMETHYL-)
• 65970-71-0(HEXANEDIOIC ACID, 3-(1,1-DIMETHYLETHYL)-, (S)-)
• 87272-20-6(MEDICA 16)
• 95823-36-2(Carboxylic acids,C6-8-neo-)
• 10428-69-0(4,4-Bis(2-carboxyethyl)heptanedioic acid)
• 41302-08-3
• 115135-17-6(NONANEDIOIC ACID, 4,4,6-TRIMETHYL-)
• 78100-83-1(TETRADECANEDIOIC ACID, 7-ETHYL-7-METHYL-)